Interleukin-6 and krebs von den lungen-6 in lymphangioleiomyomatosis patients

被引：0
|
作者：
Perea, Beatrice [1 ]
D'Alessandro, Miriana [1 ]
Bergantini, Laura [1 ]
Gangi, Sara [1 ]
Zilio, Benedetta [1 ]
Cameli, Paolo [1 ]
Bargagli, Elena [1 ]
机构：
[1] Univ Siena, Dept Med & Surg Sci & Neurosci, Resp Dis & Lung Transplantat Unit, I-53100 Siena, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA3949
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease
    Benyamine, Audrey
    Heim, Xavier
    Resseguier, Noemie
    Bertin, Daniel
    Gomez, Carine
    Ebbo, Mikael
    Harle, Jean-Robert
    Kaplanski, Gilles
    Rossi, Pascal
    Bardin, Nathalie
    Granel, Brigitte
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (05) : 813 - 819
  • [42] Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
    Myeong Geun Choi
    Sun Mi Choi
    Jae Ha Lee
    Joong-Yub Kim
    Jin Woo Song
    Respiratory Research, 23
  • [43] Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
    Choi, Myeong Geun
    Choi, Sun Mi
    Lee, Jae Ha
    Kim, Joong-Yub
    Song, Jin Woo
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [44] Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis
    He, Jie
    Zhang, Jiangliu
    Ren, Xinyi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease
    Audrey Benyamine
    Xavier Heim
    Noémie Resseguier
    Daniel Bertin
    Carine Gomez
    Mikaël Ebbo
    Jean-Robert Harlé
    Gilles Kaplanski
    Pascal Rossi
    Nathalie Bardin
    Brigitte Granel
    Rheumatology International, 2018, 38 : 813 - 819
  • [46] Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review
    d'Alessandro, Miriana
    Bergantini, Laura
    Cameli, Paolo
    Vietri, Lucia
    Lanzarone, Nicola
    Alonzi, Valerio
    Pieroni, Maria
    Refini, Rosa M.
    Sestini, Piersante
    Bonella, Francesco
    Bargagli, Elena
    BIOMARKERS IN MEDICINE, 2020, 14 (08) : 675 - 682
  • [47] Krebs von den Lungen-6 (KL-6) as a diagnostic marker for pulmonary fibrosis: A systematic review and meta-analysis
    Wang, Chuanzhu
    Wang, Qingbao
    Liu, Tong
    Zhu, Jun
    Zhang, Boke
    CLINICAL BIOCHEMISTRY, 2023, 114 : 30 - 38
  • [48] Krebs von den Lungen 6 decreased in the serum and muscle of GNE myopathy patients
    Kurashige, Takashi
    Takahashi, Tetsuya
    Nagano, Yoshito
    Sugie, Kazuma
    Maruyama, Hirofumi
    NEUROPATHOLOGY, 2021, 41 (01) : 29 - 36
  • [49] Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China
    Xue, Mingshan
    Zheng, Peiyan
    Bian, Xiqing
    Huang, Zhifeng
    Huang, Huimin
    Zeng, Yifeng
    Hu, Haisheng
    Liu, Xiaoqing
    Zhou, Luqian
    Sun, Baoqing
    Wu, Jian-lin
    Zhong, Nanshan
    BIOSCIENCE TRENDS, 2020, 14 (04) : 290 - 296
  • [50] The mucin-1 568 adenosine to guanine polymorphism influences serum Krebs von den Lungen-6 levels
    Janssen, R
    Kruit, A
    Grutters, JC
    Ruven, HJ
    Gerritsen, WB
    van den Bosch, JM
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 34 (04) : 496 - 499
12345